Merck KGaA (OTCMKTS:MKKGY – Get Free Report) shares reached a new 52-week low on Wednesday . The stock traded as low as $28.82 and last traded at $28.88, with a volume of 139018 shares traded. The stock had previously closed at $29.22.
Analyst Ratings Changes
Separately, The Goldman Sachs Group started coverage on shares of Merck KGaA in a research note on Thursday, September 19th. They set a “buy” rating on the stock.
Read Our Latest Stock Analysis on Merck KGaA
Merck KGaA Stock Down 1.2 %
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Stories
- Five stocks we like better than Merck KGaA
- Using the MarketBeat Dividend Tax Calculator
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- How to Effectively Use the MarketBeat Ratings Screener
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- The 3 Best Blue-Chip Stocks to Buy Now
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.